A pharmaceutical company developing TCMCB07, a novel synthetic peptide product for the potential treatment of cachexia.

Case Studies

Showing 1 Success Stories about Software and Services used by Endevica Bio

Endevica Bio accelerates peptide drug development with Quotient Sciences' Translational Pharmaceutics

No matching case studies